Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion
about
Searching for the physiological role of glucose-dependent insulinotropic polypeptideGPR119 agonists for the treatment of type 2 diabetesThe entero-insular axis: implications for human metabolism.Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure.Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male ratsTranscriptional analysis of apoptotic cerebellar granule neurons following rescue by gastric inhibitory polypeptideGlucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas.GIP and GLP-1, the two incretin hormones: Similarities and differencesCytokines and Hormones That Contribute to the Positive Association between Fat and Bone.Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial.Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular diseaseReceptors and effects of gut hormones in three osteoblastic cell linesThe hunger games of skeletal metabolism.Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes - a review.Differential effects of PPAR-{gamma} activation versus chemical or genetic reduction of DPP-4 activity on bone quality in mice.The role of incretins in glucose homeostasis and diabetes treatment.Skeleton and glucose metabolism: a bone-pancreas loop.Regulation of Glucose Uptake and Enteroendocrine Function by the Intestinal Epithelial Insulin Receptor.Pleiotropic effects of sitagliptin in the treatment of type 2 diabetes mellitus patients.Glucose-dependent insulinotropic polypeptide (GIP) and GIP receptor (GIPR) genes: An association analysis of polymorphisms and bone in young and elderly women.Glucagon-like peptide-1(GLP-1) receptor agonists: potential to reduce fracture risk in diabetic patients?Energy Balance, Myostatin, and GILZ: Factors Regulating Adipocyte Differentiation in Belly and Bone.Anti-inflammatory role of glucose-dependent insulinotropic polypeptide in periodontitisTargeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretinsImpact of glucose-dependent insulinotropic peptide on age-induced bone loss.Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease?GIP and bariatric surgery.Glucose-dependent insulinotropic polypeptide: from pathophysiology to therapeutic opportunities in obesity-associated disorders.Diet: friend or foe of enteroendocrine cells--how it interacts with enteroendocrine cells.Update on incretin hormones.Antidiabetic therapy effects on bone metabolism and fracture risk.Influence of hormonal appetite and energy regulators on bone.Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass.Transcriptional regulatory factor X6 (Rfx6) increases gastric inhibitory polypeptide (GIP) expression in enteroendocrine K-cells and is involved in GIP hypersecretion in high fat diet-induced obesity.The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A "Me Too" or "the Special One" Antidiabetic Class?Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition.Glucose-Dependent Insulinotropic Polypeptide Receptor Deficiency Leads to Impaired Bone Marrow Hematopoiesis.Diabetes Drug Effects on the Skeleton.Pathophysiology of Bone Fragility in Patients with Diabetes.Elevated fasting and postprandial C-terminal telopeptide after Roux-en-Y gastric bypass.
P2860
Q26749221-DFB6E853-6766-4EC9-9E73-9E07340B2C00Q28259606-0C2C120B-1B4F-428C-8AD5-5F5B2ED973E9Q30365939-36CF5DEA-1008-48C5-84EC-6B015818E694Q30478488-D0E9319D-8DD2-49F1-AACD-FD5DECE02623Q33569683-2307B873-AEE3-405D-B411-E12C86DCF634Q33580451-C725458A-F697-4E52-B152-9D13963CFA64Q33603384-BD117DF0-E7CE-4224-A1F0-4C95049C04A7Q33609502-9FB4063F-A313-4AAE-8203-CD345E6C4B17Q33620265-513D8118-59ED-4186-A87C-D40887D49AEEQ33691585-0528804D-DAE2-4149-B983-61F6E4BD3256Q33939256-18193DBE-5A06-4972-B657-0D4342F9CFF3Q33975451-8E8F414D-C883-44F1-A573-414E77F645BDQ34502173-837672A2-CBF7-486D-A224-3B2B43D5CED4Q34620479-8EF15D56-5BB3-4350-9E20-DD0BE002EE6DQ34888374-905AD355-0BBE-4901-BA8E-6D001A0B9151Q34901533-DDCB7E5A-0A2A-4A49-A59C-0D59A9D61666Q35250223-CF88267E-4B7A-4125-A947-83BDE7DA3456Q36251999-6787E47B-532E-4E43-8981-271DD95046E1Q36254518-125B6D09-003A-4E05-9F37-FC1FA65B54C5Q36317203-7D0C67BA-26BB-4327-B88A-581B2F094CC1Q36410243-6FF6FAE8-AEF7-4B56-A183-39BDA427C6A8Q36465015-8D83EFAB-9F8C-4619-B107-CFAB70EF7F85Q37060832-FD3D9BE9-942E-43F0-8A34-A621E9B88614Q37091579-79B682BE-2311-485C-82A4-1EF60269FCFAQ37158691-180E3A44-DC86-41B7-9663-D757849B862DQ37779101-9FE5DDFA-73F2-4B8D-A3EA-350AB3C05E98Q37809995-B0944BB1-DD66-4454-93E7-FD8F1CA583DFQ37911549-4FB93CA0-5094-4596-87C1-7DCE37EE7E0FQ37983846-9E6FE99F-B9B4-4692-A0C7-81B6CEC3B11CQ38006504-78A1513C-754A-4931-84BC-638244D084B3Q38078009-1BB90EB3-F944-49FD-A518-C1BA88016443Q38126411-84F2ED32-DA56-4371-A142-36ACA2F8E0AAQ38134579-CD704BE1-F7C2-468E-B22F-B2F774C6F886Q38319707-9B423AC8-1B34-44A6-9679-ABEE44AE2E70Q38527885-D6CB28DB-DED9-48AC-8FDE-FBB1F4EBA2C8Q38776127-1C6D8E0D-5132-4BBE-A79F-23C8DC882363Q38934912-B287A40A-A06C-4CCE-924A-799D9B9501BAQ38999214-E07FD1C2-C964-4010-BEC7-C79EF97D2BD8Q39127683-EF124DD1-8290-4002-8EFD-B335E68733C8Q39459338-8D509874-A5A8-432E-9999-3CB9E1FCC242
P2860
Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion
description
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Juli 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/07/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/07/01)
@nl
наукова стаття, опублікована в липні 2006
@uk
مقالة علمية (نشرت في يوليو 2006)
@ar
name
Gastric inhibitory polypeptide ...... formation after food ingestion
@ast
Gastric inhibitory polypeptide ...... formation after food ingestion
@en
Gastric inhibitory polypeptide ...... formation after food ingestion
@nl
type
label
Gastric inhibitory polypeptide ...... formation after food ingestion
@ast
Gastric inhibitory polypeptide ...... formation after food ingestion
@en
Gastric inhibitory polypeptide ...... formation after food ingestion
@nl
prefLabel
Gastric inhibitory polypeptide ...... formation after food ingestion
@ast
Gastric inhibitory polypeptide ...... formation after food ingestion
@en
Gastric inhibitory polypeptide ...... formation after food ingestion
@nl
P2093
P3181
P356
P1476
Gastric inhibitory polypeptide ...... formation after food ingestion
@en
P2093
Chizumi Yamada
Katsushi Tsukiyama
Kazuhisa Bessho
Kiyoshi Tanaka
Masahiro Sato
Masahito Ogura
Naoyuki Takahashi
Nobuyuki Udagawa
Norio Amizuka
P304
P3181
P356
10.1210/ME.2005-0187
P577
2006-07-01T00:00:00Z